Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMI1 is a core component of the Polycomb Repressive Complex 1 (PRC1), a multiprotein complex that maintains transcriptional repression of target genes through chromatin modification. It plays critical roles in stem cell self-renewal, cell cycle regulation, and DNA repair, and is implicated as an oncogene in various cancers. It acts by mediating monoubiquitination of histone H2A at lysine119.
Inhibits gene transcription by monoubiquitination of histone H2A at lysine119 as a core component of the Polycomb Repressive Complex 1 (PRC1).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycomb complex protein BMI-1 (BMI1).